← Back to Deal Tracker
→AcquisitionVerified
OpenAI
↓
Orchestra Bio

Deal Value

Undisclosed

Announced

Wednesday, October 21, 2026

Deal Details

OpenAI acquired Orchestra Bio to combine its drug-development coordination platform and team with Rosalind.

A company acquisition including technology, team, and intellectual property.

Related News

OpenAI acquires Orchestra Bio to expand drug research

OpenAI announced its acquisition of Orchestra Bio on October 20, 2026. The company will combine Orchestra's team and drug-development coordination technology with its Rosalind life sciences tools. ([openai.com](https://openai.com/index/openai-to-acquire-orchestra-bio/))

Oct 21, 2026
View Original Source↗
More Acquisition DealsOpenAI DealsOrchestra Bio Deals

Related Deals

→Acquisition

Amazon → Decart.ai Inc.

UndisclosedOct 12, 2026
→Acquisition

Nvidia → Reflection AI

UndisclosedOct 11, 2026
☁Compute

Nvidia → Genesis Mission Consortium

UndisclosedOct 8, 2026
◎Research

AMD → U.S. Department of Energy

UndisclosedOct 7, 2026
⊕Partnership

OpenAI → ForthFocus

UndisclosedOct 6, 2026
→Acquisition

Schneider Electric → PTC

UndisclosedOct 5, 2026